From: Integrating multiple ‘omics’ analyses identifies serological protein biomarkers for preeclampsia
Characteristic | PE | Control | pvalue |
---|---|---|---|
n = 32 (50%) | n = 32 (50%) | ||
Concurrent medical conditions/Clinical features | 0.35 | ||
Anemia | 0 (0) | 2 (6.2%) | |
Asthma, other: chlamydia (2009) | 1 (3.1%) | 0 (0) | |
Asthma, other: Group B streptococcus carrier, maternal deficiency anemia, thrombocytopenia | 1 (3.1%) | 0 (0) | |
Crohn’s disease | 0 (0) | 1 (3.1%) | |
Diabetes - Type II | 2 (6.2%) | 1 (3.1%) | |
Diabetes - Type II, morbid obesity, other: history of depression | 1 (3.1%) | 0 (0) | |
Diabetes - Type II, other: left breast lump | 1 (3.1%) | 0 (0) | |
Diabetes (gestational) | 1 (3.1%) | 3 (9.4%) | |
Diabetes (gestational), obesity | 1 (3.1%) | 0 (0) | |
Fatty liver | 1 (3.1%) | 0 (0) | |
Hyperthyroidism | 1 (3.1%) | 0 (0) | |
Migraines, urinary tract infection (UTI) | 1 (3.1%) | 0 (0) | |
None | 19 (59.4%) | 24 (75%) | |
Other: borderline gestational diabetes | 1 (3.1%) | 0 (0) | |
Other: hepatitis C antibody = reactive | 0 (0) | 1 (3.1%) | |
Other: history of cardiac surgery at birth, marginal cord insertion | 1 (3.1%) | 0 (0) |